Preparations of intravenous immunoglobulins diminish the number and proinflammatory response of CD14+CD16++ monocytes in common variable immunodeficiency (CVID) patients

Copyright © 2011 Elsevier Inc. All rights reserved.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 139(2011), 2 vom: 26. Mai, Seite 122-32
Auteur principal: Siedlar, Maciej (Auteur)
Autres auteurs: Strach, Magdalena, Bukowska-Strakova, Karolina, Lenart, Marzena, Szaflarska, Anna, Węglarczyk, Kazimierz, Rutkowska, Magdalena, Baj-Krzyworzeka, Monika, Pituch-Noworolska, Anna, Kowalczyk, Danuta, Grodzicki, Tomasz, Ziegler-Heitbrock, Loems, Zembala, Marek
Format: Article en ligne
Langue:English
Publié: 2011
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Clinical Trial Journal Article Research Support, Non-U.S. Gov't Antibodies, Monoclonal Antigens, CD FCGR3B protein, human Fc gamma receptor IIB GPI-Linked Proteins HLA-DR Antigens IL10 protein, human plus... Immunoglobulins, Intravenous Lipopolysaccharide Receptors Lipopolysaccharides Receptors, IgG Tumor Necrosis Factor-alpha Interleukin-10 130068-27-8 Interleukin-12 187348-17-0